Results 191 to 200 of about 118,394 (314)

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Associations of Serum Amphiregulin Levels With Kidney Failure and Mortality: The Chronic Renal Insufficiency Cohort (CRIC). [PDF]

Kidney Med
Schmidt IM, Kefalogianni E, Zhao R, Verma A, Sabbisetti V, Rahman M, Pradhan N, Srivastava A, He J, Chen J, Waikar SS, Herrlich A, CRIC Study Investigators.   +12 more
europepmc   +1 more source

A generalized covariate-adjusted top-scoring pair algorithm with applications to diabetic kidney disease stage classification in the Chronic Renal Insufficiency Cohort (CRIC) Study. [PDF]

BMC Bioinformatics, 2023
Kwan B, Fuhrer T, Montemayor D, Fink JC, He J, Hsu CY, Messer K, Nelson RG, Pu M, Ricardo AC, Rincon-Choles H, Shah VO, Ye H, Zhang J, Sharma K, Natarajan L.   +15 more
europepmc   +1 more source

Present state and prospects of countermeasure for renal insufficiency IV. Cause and countermeasure of chronic renal insufficiency 1. Chronic primary glomerulonephritis.

, 1998
土肥 和紘, 金内 雅夫
openalex   +2 more sources

Letter from the authors of “Improved Growth in Young Children with Severe Chronic Renal Insufficiency Who Use Specified Nutritional Therapy,” which appeared on pages 2418–2426 of the November 2001 issue of JASN. [PDF]

, 2002
Rulan S. Parekh, William E. Smoyer, Joan L. Milne, David B. Kershaw, Aileen B. Sedman, Joseph T. Flynn, Timothy E. Bunchman   +6 more
openalex   +1 more source

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

Effectiveness and safety of dupilumab in moderate-to-severe atopic dermatitis patients with chronic renal insufficiency: a real-world retrospective study in China. [PDF]

MedComm (2020)
Peng C, Cao Q, Xiong F, Xu H, Li J.
europepmc   +1 more source

Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort. [PDF]

Am J Nephrol, 2021
Cho ME, Sweeney C, Fino N, Greene T, Ramkumar N, Huang Y, Ricardo AC, Shafi T, Deo R, Anderson A, Mills KT, Cheung AK, CRIC Study Investigators.   +12 more
europepmc   +1 more source

Disease state and treatment of chronic renal insufficiency.

, 1995
酒井 紀
openalex   +2 more sources

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source